Get started
AMD Harmonic Elliott Wave and Hurst Cyclic AnalysisLet’s revisit the key points from my last update on AMD, published on November 27th: We are currently correcting the bullish move from October 2022 to March 2024. Wave A of the second zigzag (labeled 'y') is nearing completion. The October 2023 trough aligns with an 80-week (80W) cycle trough. The first 20-week (20W) cycle within this 40W cycle was anticipated around December 18th. A rally is expected to follow before entering the extreme bearish phase. The 80W cycle trough is projected for early April 2025. Although the 20W cycle trough took slightly longer to form than expected, the overall analysis remains intact. We are currently progressing through wave B of y of (II), which I believe could push prices as high as 144. The 80W cycle trough is now projected for early May 2025.
NASDAQ:AMD
by bamdadsalarieh
Halftime Update: COIN on a Crypto Rebound Play?After CRYPTOCAP:BTC rebounded above $100K and has since settled, stocks such as COIN has of course benefitted by seeing $1.162B in Trading Volume going into Halftime of Today's Trading Session. It's currently trading above a Longer Resistance Level (as support) so this could push up along the bottom of our Purple Trend you see there, bouncing downward, delivery better entries on it's way up. With that being said, we could see a $240-$246 retest before the push higher as it has dipped twice to those levels since Mid-Dec. 2024. Just watching for now but stay tuned for more at @MyMIWallet by visiting our website and connecting with us everywhere you are! We'll be there!
NASDAQ:COINLong
by MyMIWallet
Amd - It Comes Down To This Support!Amd ( NASDAQ:AMD ) is retesting massive support: Click chart above to see the detailed analysis👆🏻 For more than three years, we have been seeing a quite volatile consolidation phase on Amd. Looking at recent price history though, Amd just came back to retest a massive horizontal support level and if we see bulls taking over, a rally of +100% is very possible. Levels to watch: $120, $240 Keep your long term vision, Philip (BasicTrading)
NASDAQ:AMDLong
by basictradingtv
28
1/22/25 - $fslr - r/r merits a punt long <$1751/22/25 :: VROCKSTAR :: NASDAQ:FSLR r/r merits a punt long <$175 - my fav solar name remains NASDAQ:NXT , don't get it twisted - but if say NASDAQ:NXT is my $tsm.... NASDAQ:FSLR is my $nvda. it's a bit higher octane, bigger cap. more headline grabby etc. - double the mgns of NASDAQ:NXT , but big capex (why i like NASDAQ:NXT is it's much capital-lighter) - but don't forget agent orange has elon on the team and guess who remains +ve solar. yuh yuh credits this credits that. look... if we r going to "drill drill drill" - and don't say i didn't write about this event - the best scenario is a balance generation profile and we export a lot of oil. - does it take time? is this the low V? no clue fam. - but the sell off looks like a quick buck/ punt sub $175. so i've done some S calls to size up gross without touching my notional. just flagging in case you're inclined to opine, troll me or otherwise just follow along. V
NASDAQ:FSLRLong
by VROCKSTAR
TARS demonstrates strong technical perfomanceTechnical Analysis TARS demonstrates strong technical performance, indicating significant investor interest and upward momentum. Recent Price Performance Current Price: $47.81 52-Week Price Change: +99.06% The stock has consistently outperformed, suggesting robust demand. Key Technical Indicators Relative Strength Index (RSI): 75.51 Indicates the stock is in overbought territory, potentially signaling a price correction in the near term. Moving Average Convergence Divergence (MACD): 2.64 Supports the overbought status but also reflects bullish momentum. Moving Averages: 50-Day Moving Average: Price remains significantly above this level. 200-Day Moving Average: Similarly, the price trend is well above, indicating sustained long-term growth. Market Sentiment Analysts maintain a bullish outlook based on the technical setup. However, the overbought indicators suggest caution for short-term investors. Fundamental Analysis Fundamentally, Tarsus Pharmaceuticals offers a mixed profile with promising growth potential but notable financial risks. Financial Performance Revenue (Last 12 Months): $129.62 million Net Loss: $134.34 million Earnings Per Share (EPS): - $3.70 Reflects a loss-making position, but this is not uncommon for a biopharmaceutical company investing heavily in research and development. Growth Potential The company operates in a niche pharmaceutical market, focusing on unmet medical needs. Pipeline drugs and upcoming FDA approvals could drive future growth. Valuation and Analyst Sentiment Analyst Consensus: Strong Buy Average Price Target: $55.60 (implying a potential upside of approximately 17%). However, fundamental valuation tools, such as those from Validea, score TARS at 55%, suggesting moderate fundamental strength. Strengths and Risks Strengths: Strong technical momentum with a clear upward trend. Positive analyst outlook with significant upside potential. Promising drug pipeline and growth opportunities in niche markets. Risks: Overbought technical indicators suggest potential near-term price corrections. Ongoing net losses may limit financial flexibility. Dependence on successful clinical trials and regulatory approvals. Conclusion Tarsus Pharmaceuticals is a stock with strong technical appeal and considerable growth potential in the biopharmaceutical sector. However, its current overbought status and financial risks should prompt investors to approach with caution. Long-term investors who believe in the company’s pipeline may find this an attractive opportunity, while short-term traders should be mindful of potential price volatility.
NASDAQ:TARS
by swingstocktraders
1
Netflix Caught in a Bearish Crab.The Netflix stock exhibited robust growth in 2024, primarily driven by a surge in subscribers and expansion into new markets. However, a bearish Crab harmonic pattern has been identified on the chart, suggesting a potential significant price correction. The pattern indicates that the stock price might initiate a decline from the 1029 level. The XA, AB, BC, and CD legs of the pattern, defined by Fibonacci ratios, clearly outline the bearish formation. When coupled with other technical indicators, this pattern provides a compelling bearish signal for Netflix. Nevertheless, it's essential to remember that technical analysis alone is insufficient for investment decisions. Fundamental factors, such as increasing competition, content costs, and changes in consumer preferences, should also be considered. Investors are advised to conduct thorough research and potentially consult with a financial advisor before making any investment decisions based solely on this technical analysis. SEYED.
NASDAQ:NFLX
by SEYED98
CELH Buy Setup - 1/27 Risk/Reward Opportunity at Strong SupportNASDAQ:CELH is offering another great buying opportunity after my stop-loss was triggered earlier (previous idea linked below). The price has returned to a strong support level, aligned with a bullish trendline that’s been guiding the stock upward. A small double bottom has formed, adding further confidence to the setup, alongside a bullish engulfing pattern and increased buying volume. The setup offers a solid 1:27 risk-to-reward ratio, with the next target being the all-time high (ATH). If support holds, there’s significant upside potential ahead.
NASDAQ:CELHLong
by PattRec
WM Technology | MAPS | Long at $1.00WM Technology NASDAQ:MAPS provides ecommerce and compliance software solutions to retailers and brands in cannabis market in the United States and internationally. After it's de-SPAC in 2020, it soared to $29.50 and now can be found for around $1.00. It's been consolidating at these lows for almost two years, and it may be gaining algorithmic traction for a move soon based on my selected simple moving average (SMA). Often (but not always), when this SMA gets close to the price, there is a pop to the historical SMA. Currently, it is in a personal buy zone at $1.00. Target #1 = $1.50 Target #2 = $2.00
NASDAQ:MAPSLong
by WorthlessViews
Purple Innovation | PRPL | Long at $0.93Purple Innovation / Mattress NASDAQ:PRPL is facing a Nasdaq delisting if it can't stay above $1 by early 2025. However, a positive move up (from a technical analysis perspective) may be brewing. My historical simple moving average lines are approaching the price, which more often than not means a future price jump. But the question is, will it occur before the scheduled delisting? Google Trends shows the largest spike in the search for "Purple Mattress" occurred between June to December 2024. The CEO of NASDAQ:PRPL bought $203k worth of shares around this initial spike. The company is not expected to be profitable for some time, but I am more interested in the short-term move here vs the strength of the company, long-term. So, while this is a "risky" play, especially with the approaching Nasdaq delisting, it's interesting from a technical analysis end. At $0.93, NASDAQ:PRPL is in a personal buy zone through January 2025. Target #1 = $1.14 Target #2 = $1.30 Target #3 = $1.50 Target #4 = $1.63
NASDAQ:PRPLLong
by WorthlessViews
CVS Health Corp | CVS | Long at $43Not much to write about here except the stock has reentered the "crash" simple moving average area (see green lines). Often, this signals an overall bottom, but it doesn't mean a further dip below $40 isn't possible in the near-term. Personally, I can't ignore this reentry and thus have started a position at $43 (after closing out a previous position in October in the $60's). The company has a lot of headwinds, but if Walgreens NASDAQ:WBA is also in trouble, is NYSE:CVS too big to fail in the short-term? Target #1 = $53.00 Target #2 = $60.00 Target #3 = $65.00 Target #4 = $68.00
NYSE:CVSLong
by WorthlessViews
1
Liberty Latin America | LILA | Long at $6.37Liberty Latin America NASDAQ:LILA is a leading telecommunications company operating in over 20 countries across Latin America and the Caribbean under the consumer brands Flow, Liberty Communications, Más Móvil, BTC and Liberty Costa Rica. Insiders have been loading up shares after the recent drop post earnings, which got my attention. The company is expected to be profitable starting in 2025, but its stock has taken a tremendous hit over the past few years. On paper, the future looks bright for this large telecommunications company and it is trading at good value compared to peers and industry. From a technical analysis perspective, my selected historical simple moving average lines are connecting with the price (which often means a future breakout). The recent dip, based on the financials and insider buying, may be a hidden opportunity for a future run up and the stock consolidates. However, as always, stay cautious. Thus, at $6.37, NASDAQ:LILA is in a personal buy zone. Target #1 = $7.00 Target #2 = $8.00 Target #3 = $9.00 Target #4 = $10.00
NASDAQ:LILALong
by WorthlessViews
Lockheed Martin | LMT | Long at $472.00Lockheed Martin $NYSE:LMT. The war machine keeps turning... while there may some temporary "peace" with the new Trump administration, it is just never (unfortunately) permanent. The price has entered my historical simple moving average area. If there is a bounce, I expect it to be between the current price of $466.00 and $450.00. I've started a small position at $472.00 and will grab more shares if it hits $450. Now, if the aerospace and defensive industry goes through a downtrend with the new presidential administration, I expect the price to fill the daily price gap near the low $400s - which is only an even better bargain, in my opinion. Target #1 = $500.00 Target #2 = $535.00 Target #3 = $610.00
NYSE:LMTLong
by WorthlessViews
Teladoc Health | TDOC | Long at $9.91Teladoc Health NYSE:TDOC - Initial position started at $9.91 with the potential for the price gap in the $7's to be closed in the near future (likely another entry there unless fundamentals change) Pros: User base of over 90 million and growing Revenue grew from $555 million in 2019 to $2.6 billion through Q3 of 2024 Positive free cash flow since 2021 Low debt (debt to equity ratio around 1x) AI integration and partnership with Amazon and Brightline Historical simply moving average is approaching price, which often leads to a jump or change in downward momentum in the longer-term Cons: Currently unprofitable and not forecast to become profitable over the next 3 years Lots of insider selling and exercising of options No dividend Daily price gap in the $7 dollar range which may close prior to move up Targets through 2027 : $14.20 $20.00 $27.00 $35.00 $55.00 (long-term, positive outlook)
NYSE:TDOCLong
by WorthlessViews
1